Interferon-γ deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet

International Journal of Molecular Medicine

Volumn 30, Issue 3, 2012, Pages 545-552

  Tavakoli, Nasim Nik ^a   Harris, Angie K ^a   Sullivan, David R ^b   Hambly, Brett D ^a   Bao, Shisan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Endothelial injury; IFN ; Neointimal formation; Restenosis

Indexed keywords

GAMMA INTERFERON; LIPID; PLATELET DERIVED GROWTH FACTOR B;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; CELL COMPOSITION; CELL INFILTRATION; CELL PROLIFERATION; ENDOLUMINAL ENDOTHELIUM INJURY; ENDOTHELIUM INJURY; GENE DELETION; HISTOPATHOLOGY; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LIPID BLOOD LEVEL; MACROPHAGE; MALE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REENDOTHELIALIZATION; RESTENOSIS; SMOOTH MUSCLE FIBER; TISSUE REGENERATION; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; BODY WEIGHT; CELL PROLIFERATION; DIET, ATHEROGENIC; INTERFERON-GAMMA; LIPIDS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PLATELET-DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

EID: 84865165123     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1034     Document Type: Article

References (37)

1. Li JJ, Nie SP, Zhang CY, Gao Z, Zheng X and Guo YL: Is inflammation a contributor for coronary stent restenosis? Med Hypotheses 68: 945-951, 2007. (Pubitemid 46274028)
2. Bennett MR: In-stent stenosis: pathology and implications for the development of drug eluting stents. Heart 89: 218-224, 2003.
3. Schwartz RS, Holmes DR Jr and Topol EJ: The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 20: 1284-1293, 1992.
4. Harvey EJ and Ramji DP: Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? Cardiovasc Res 67: 11-20, 2005.
5. Schroder K, Hertzog PJ, Ravasi T and Hume DA: Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189, 2004. (Pubitemid 38174573)
6. Leon ML and Zuckerman SH: Gamma interferon: a central mediator in atherosclerosis. Inflamm Res 54: 395-411, 2005. (Pubitemid 41609377)
7. Tellides G, Tereb DA, Kirkiles-Smith NC, et al: Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 403: 207-211, 2000. (Pubitemid 30050965)
8. Nunokawa Y and Tanaka S: Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun 188: 409-415, 1992.
9. Hansson GK, Jonasson L, Holm J, Clowes MM and Clowes AW: Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res 63: 712-719, 1988.
10. Muhl H and Pfeilschifter J: Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 3: 1247-1255, 2003.
11. Kusaba K, Kai H, Koga M, et al: Inhibition of intrinsic interferon-gamma function prevents neointima formation after balloon injury. Hypertension 49: 909-915, 2007. (Pubitemid 351664225)
12. Paroli M, Mariani P, Accapezzato D, et al: Modulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularization. Clin Immunol 112: 78-84, 2004. (Pubitemid 38781060)
13. Zohlnhofer D, Richter T, Neumann F, et al: Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell 7: 1059-1069, 2001. (Pubitemid 32525752)
14. Hansson GK and Holm J: Interferon-gamma inhibits arterial stenosis after injury. Circulation 84: 1266-1272, 1991.
15. Busnelli M, Froio A, Bacci ML, et al: Pathogenetic role of hypercholesterolemia in a novel preclinical model of vascular injury in pigs. Atherosclerosis 207: 384-390, 2009.
16. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A and Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742, 1993. (Pubitemid 23114658)
17. Harris AK, Shen J, Radford J, Bao S and Hambly BD: GM-CSF deficiency delays neointima formation in a normolipidemic mouse model of endoluminal endothelial damage. Immunol Cell Biol 87: 122-130, 2009.
18. Shen J, White M, Husband AJ, Hambly BD and Bao S: Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model. Eur J Pharmacol 548: 123-128, 2006. (Pubitemid 44397011)
19. Bao S, Beagley KW, Murray AM, et al: Intestinal IgA plasma cells of the B1 lineage are IL-5 dependent. Immunology 94: 181-188, 1998. (Pubitemid 28267473)
20. Middleton J, Americh L, Gayon R, et al: A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 206: 260-268, 2005. (Pubitemid 40903190)
21. Pompili VJ, Gordon D, San H, et al: Expression and function of a recombinant PDGF B gene in porcine arteries. Arterioscler Thromb Vasc Biol 15: 2254-2264, 1995. (Pubitemid 26001429)
22. Murayama H, Takahashi M, Takamoto M, et al: Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury. Cardiovasc Res 80: 175-180, 2008.
23. Aoyagi M, Yamamoto M, Wakimoto H, Azuma H, Hirakawa K and Yamamoto K: Immunohistochemical detection of Ki-67 in replicative smooth muscle cells of rabbit carotid arteries after balloon denudation. Stroke 26: 2328-2332, 1995.
24. Kurki P, Ogata K and Tan EM: Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods 109: 49-59, 1988. (Pubitemid 18093761)
25. Song JM, Kim HS, Park SJ, et al: Effect of hypercholesterolemia on macrophage infiltration after balloon injury to rabbit iliac artery. Jpn Circ J 65: 117-122, 2001.
26. Billett MA, Adbeish IS, Alrokayan SA, Bennett AJ, Marenah CB and White DA: Increased expression of genes for platelet-derived growth factor in circulating mononuclear cells of hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 16: 399-406, 1996. (Pubitemid 26084315)
27. Hansson GK: Inflammatory mechanisms in atherosclerosis. J Thromb Haemost 7 (Suppl 1): 328-331, 2009.
28. Whitman SC, Ravisankar P and Daugherty A: IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. J Interferon Cytokine Res 22: 661-670, 2002. (Pubitemid 35034524)
29. Vergnes L, Phan J, Strauss M, Tafuri S and Reue K: Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 278: 42774-42784, 2003. (Pubitemid 37345887)
30. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW and Lichtman AH: Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 23: 454-460, 2003. (Pubitemid 36337222)
31. Kipshidze N, Dangas G, Tsapenko M, et al: Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 44: 733-739, 2004. (Pubitemid 39099565)
32. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al: Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 94: 3098-3102, 1996. (Pubitemid 26427473)
33. Danenberg HD, Fishbein I, Gao J, et al: Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 106: 599-605, 2002. (Pubitemid 34827711)
34. Libby P, Schwartz D, Brogi E, Tanaka H and Clinton SK: A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 86: 11147-11152, 1992.
35. Maiellaro K and Taylor WR: The role of the adventitia in vascular inflammation. Cardiovasc Res 75: 640-648, 2007. (Pubitemid 47238746)
36. Heldin CH and Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999. (Pubitemid 29473317)
37. Zhou Z, Lauer MA, Wang K, et al: Effect of anti-tumor necrosis factor-alpha polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic model. Atherosclerosis 161: 153-159, 2002. (Pubitemid 34214831)